LAVD (Left Ventricular Assist Device)

An Overview

Left Ventricular Assist Devices (LVADs) are advanced mechanical devices designed to support individuals with end-stage heart failure. They are commonly used as a bridge to heart transplantation for patients with unstable conditions or as destination therapy for those ineligible for transplants.

These devices assist the heart’s left ventricle in pumping blood to the body, improving quality of life and survival rates. LVADs are not a replacement for the heart but offer essential support to its function.

What is an LVAD?

An LVAD is an implantable mechanical pump that operates with a battery. It helps the heart pump blood effectively, alleviating strain on the organ. LVADs are suitable for patients with chronic heart failure who have not responded to maximum medical treatment.

Alternate Name

Mechanical Circulatory Support Device

Indicators for LVAD Treatment

LVADs are used for conditions such as:

Severe symptomatic heart failure.
Postpericardiotomy shock.
Severe left ventricular dysfunction.
Advanced heart failure with optimal medical management.
Patients awaiting heart transplantation.
Heart failure accompanied by other organ dysfunctions.

Who May Need an LVAD?

LVADs are beneficial for:

Patients awaiting a heart transplant who are unstable.
Individuals too old or with other health conditions preventing transplantation.
Patients recovering from heart surgery but needing additional support.
Those with advanced conditions like myocarditis or dilated cardiomyopathy.

LVADs are categorized by duration:

Short-Term: For temporary support in critical conditions.
Intermediate-Term: Support for up to 500 days.
Long-Term: Continuous support for advanced heart failure outside the hospital.

Eligibility and Contraindications

Eligible Patients:

Those on the transplant list.
Individuals needing prolonged recovery post-heart surgery.
Patients ineligible for heart transplantation.

Contraindications:

Clotting disorders.
Severe kidney, liver, or lung disease.
Active infections.

Diagnostic Tests for LVAD Placement

Before undergoing an LVAD procedure, doctors may perform:

Electrocardiogram (ECG).
Metabolic stress test.
Echocardiogram.
Cardiac MRI or catheterization.
CT scans and X-rays.
Blood tests.

LVAD Procedure

Preoperative Phase

Patients undergo evaluations, counseling, and relevant investigations. They may be advised to stop eating at least 12 hours before surgery and prescribed medications to minimize risks.

Operative Phase

Anesthesia and Access: General anesthesia is administered, and the breastbone is opened.
Device Placement:
- One end of the LVAD connects to the left ventricle, and the other to the aorta.
- A driveline exits the abdomen and connects to an external power source.
Testing and Closure: The device is tested, and the chest is closed.

Postoperative Phase

Patients are monitored in intensive care and may require temporary breathing support. Recovery involves medications, lifestyle adjustments, and regular follow-ups.

Benefits of LVAD

Improves blood flow to vital organs, enhancing function.
Alleviates symptoms, improving quality of life.
Serves as an alternative for patients ineligible for transplants.
Can support advanced heart failure cases.
In some cases, the heart may regain normal function.

Precautions After LVAD Placement

Take medications as prescribed.
Maintain a healthy lifestyle and manage blood pressure.
Keep extra controllers and fully charged spare batteries.
Avoid disconnecting the driveline or power sources.
Manage stress and maintain a healthy BMI.

Potential Complications

Common Risks:

Blood vessel damage.
Blood clots.
Device malfunction.
Internal bleeding.

Rare Risks:

Heart attack or right heart failure.
Respiratory or kidney failure.
Death (in rare cases).

Seek immediate medical assistance if complications arise.

LVADs offer a lifeline for individuals with advanced heart failure, providing crucial support and improving overall health outcomes.

Neuromodulation

Orthopaedics

Neurosurgery

Spine Care

Neurology